drugset / Trial / NCT02047552

RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone

NCT02047552

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this trial is to determine if the combination of goal directed iron supplementation and hepcidin mitigation can safely eliminate both the serum and bone marrow iron debt of anemic, critically ill trauma patients with functional iron deficiency.

Timeline

Start
2015-01
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown 100 mg Intravenous
Subject Oxandrolone Small molecule 10 mg Oral